最近关于T细胞急性淋巴细胞白血病中长非编码RNAs生物发生,功能和治疗潜力的进展
Parminder Kaur1, Pankaj Sharma1, Prateek Bhatia1
1Haematology-Oncology Unit, Department of Paediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Discover oncology
|November 29, 2024
概括
长非编码RNAs (lncRNAs) 是T细胞急性淋巴细胞白血病 (T-ALL) 的关键调节者. 本综述探讨了lncRNAs作为侵略性T-ALL的有前途的诊断和治疗点,解决目前的数据限制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- T细胞急性淋巴细胞白血病 (T-ALL) 是一种具有高复发率的侵袭性癌症,通常与预后不佳有关.
- 目前对T-ALL病理生理学的理解受到遗传和转录基因数据不足的限制,需要对新的治疗点进行进一步的研究.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在癌症发展中的作用,包括瘤增殖和转移.
研究的目的:
- 审查 lncRNAs 在 T-ALL.ALL 中的表征,生物合成和功能作用.
- 突出 lncRNAs 作为下一代生物标志物和T-ALL 治疗的治疗点的潜力.
主要方法:
- 对T-ALL和其他癌症中的lncRNAs现有研究的文献综述.
- 分析与T-ALL病理生理学相关的当前遗传和转录基因数据.
- 综合有关癌症中lncRNA调节和功能的信息.
主要成果:
- lncRNAs在调节各种癌症的瘤增殖和转移方面发挥着重要作用.
- 新出现的证据表明,lncRNAs参与了T-ALL.背后的分子机制.
- lncRNAs具有潜力作为诊断和预后的生物标志物,以及治疗点.
结论:
- lncRNAs代表了开发T-ALL.新型诊断,预后和治疗策略的有希望的领域.
- 进一步研究T-ALL中的lncRNA功能对于推进治疗选择至关重要.
- 向 lncRNAs 可能为打击侵略性T-ALL和降低复发率提供一个新的途径.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:27Cytotoxic T Cells-mediated Immune Response
849
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
849